Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04382521 · ClinicalTrials.gov registry record · NA
A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT04382521: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04382521 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04382521, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This is a randomized pilot trial to examine the feasibility, acceptability, and preliminary efficacy of an adaptive text message intervention (TMI) to promote well-being and health behavior adherence in 60 patients with two or more cardiac risk conditions (hypertension, type 2 diabetes, or hyperlipidemia).
Interventions
- BEHAVIORAL Text Message Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2023-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04382521
The ClinicalTrials.gov registry entry for NCT04382521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text Message Intervention is the first listed.
NCT04382521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04382521 about?
NCT04382521 is a clinical study titled "A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions". This is a randomized pilot trial to examine the feasibility, acceptability, and preliminary efficacy of an adaptive text message intervention (TMI) to promote well-being and health behavior adherence in 60 patients with two or more cardiac risk conditions (hypertension, type 2 diabetes, or hyperlipi...
What is the current status of trial NCT04382521?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2020-09-22. Estimated completion is 2023-04-15.
What interventions are being tested in trial NCT04382521?
The interventions under investigation include: Text Message Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04382521?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.